A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends

Abstract The cystic fibrosis (CF) community seeks to explain heterogeneous outcomes of pulmonary exacerbation (PEX) treatment. Serum and sputum inflammatory mediators may identify people with CF (PwCF) at risk for suboptimal responses. However, lack of an established association between response phe...

Full description

Bibliographic Details
Main Authors: Alex H. Gifford, Deepika Polineni, Jianghua He, Jessica L. D’Amico, Dana B. Dorman, Molly A. Williams, Amanda B. Nymon, Akshu Balwan, Theodore Budden, Jonathan B. Zuckerman
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-84041-y